PhD Position in Molecular Signaling Pathways in Myogenesis and Neuromuscular Junction Biology
Friedrich-Alexander University Erlangen-Nürnberg (FAU) in Germany is advertising a
fully funded PhD position
in the
Institute of Biochemistry
on
molecular signaling pathways in myogenesis and neuromuscular junction (NMJ) biology
, with a particular emphasis on the
Hippo pathway
.
The project aims to uncover how Hippo signaling regulates
muscle development
,
muscle regeneration
, and
NMJ integrity
. The research combines
transgenic mice
, genetic tools,
CRISPR/Cas9
screens, multi-omics, transcriptomics/proteomics, and high-resolution imaging to study signaling mechanisms relevant to neuromuscular disease, including
ALS
and
myasthenia
.
Successful applicants will carry out in vivo mouse experiments, NMJ electrophysiology, cell/tissue validation, immunohistochemistry, 3D confocal and electron microscopy, data analysis with bioinformatics tools, and scientific writing/presentations. The role is designed for a motivated PhD student interested in molecular biology, cell biology, biochemistry, neuroscience, omics, and imaging-based disease research.
Eligibility:
applicants should hold an M.Sc. in molecular/cell biology, biochemistry, or a related field. Practical experience with mouse work is preferred; a FELASA certificate is an advantage. Additional experience in histology, qPCR, omics, imaging software (ZEN, Fiji), and statistics is requested. Strong English skills and independent research ability are expected.
Funding and duration:
the position is fully funded through a DFG project for
3 years
.
Deadline:
15 September 2026.
Start date:
1 October 2026.
How to apply:
send a CV, a one-page cover letter (experience, project ideas, motivation), and 2 references to
[email protected]
. The posting explicitly states:
No AI applications
.
